Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury

Area of Science:

• Hepatology
• Mitochondrial Biology
• Toxicology

Background:

• Chronic ethanol consumption leads to mitochondrial dysfunction and liver injury.
• Alcoholic liver disease (ALD) is a major global health concern with limited treatment options.
• Mitochondrial damage is a key factor in the progression of ALD.

Purpose of the Study:

• To investigate the protective effects of ursodeoxycholate (UDC) against ethanol-induced mitochondrial liver injury in a rat model.
• To determine if UDC can ameliorate impaired mitochondrial respiration and morphology caused by chronic alcohol exposure.
• To assess UDC's potential role in mitigating the progression of alcoholic liver injury.

Main Methods:

• Rats were fed ethanol or control liquid diets for 5 weeks, with or without UDC supplementation.
• Mitochondrial respiratory function was assessed using oxygen electrode measurements (respiration rates, respiratory control ratio, P/O ratio).
• Mitochondrial number and size were quantified using electron microscopy and computer-assisted analysis.

Main Results:

• Ethanol-fed rats showed impaired mitochondrial energy production (33% decrease in V3, 25% decrease in RC, 15% decrease in P/O).
• UDC treatment in ethanol-fed rats improved ATP synthesis (35% increase in V3, 8% increase in P/O) and normalized respiratory parameters.
• Ethanol exposure reduced mitochondrial number (29% decrease) and increased size (74% increase), effects normalized by UDC.

Conclusions:

• Ursodeoxycholate (UDC) demonstrates significant protective effects against ethanol-induced mitochondrial liver injury.
• UDC improves mitochondrial ATP synthesis and preserves liver mitochondrial morphology in the context of chronic alcohol consumption.
• These findings suggest UDC may be a potential therapeutic agent for alcoholic liver disease by reducing mitochondrial damage and fat accumulation.